Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.
Academic rigour, journalistic flair
Articles on Pandemic
Displaying 921 - 940 of 1583 articles
Almost all food safety authority from most countries in the world agreed that no strong scientific proof that SARS-CoV-2 is transferable through food chain.
Migrant workers’ families suffer from limited access to pandemic-related health care and loss of income.
Clear messaging about who needs to get tested is better than stigmatising people who are understandably worried about their health.
Everything you need to know about non-woven polypropylene, the fabric now recommended for use as a filter in cloth face masks: What it is, what to look for and where to find it.
More states are adding mask mandates as COVID-19 cases soar. If you’re traveling, shopping or seeing friends and family in person, masks are a crucial protective measure.
The pandemic is bringing up tough new questions as parents and grandparents develop advance care plans. Here’s how to start the conversation.
The continued entrapment of African countries in the global circuit of capital and its proclivity to large scale accumulation imperils the ability of many to cope with the pandemic.
Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?
As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?
The pandemic has put a spotlight on a once little-discussed disorder – hoarding. But hoarding disorder is not what you might think.
New legislation would give the ADF more power to respond to future bushfires and other disasters. But questions remain about the scope of this involvement and how ADF personnel would be deployed.
In the current pandemic, finding the right balance between the protection of public health and respecting civil liberties has proven to be supremely difficult.
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Here’s how governments can get more people to follow COVID-19 guidelines.
There’s no guarantee future COVID-19 vaccines will work in the elderly. So we can consider vaccinating the young first to protect them. Here’s what we need to work out first.
Biden will begin his presidency in the midst of a global public health crisis that’s already killed over 240,000 people in the US alone. His team is already planning how to get COVID-19 under control.
Watch two of Australia and New Zealand’s top vaccine and virus experts answering questions about COVID-19. This was filmed at a Conversation reader event with Avid Reader bookshop.
COVID-19 and holiday family gatherings are not a good pair. But taking the right precautions before, during and after the family gets together can greatly reduce coronavirus risk this holiday season.
Job Board
-
PhD Scholarship
-
Senior Lecturer, HRM or People Analytics
-
Senior Research Fellow - Neuromuscular Disorders and Gait Analysis
-
Centre Director, Transformative Media Technologies
-
Postdoctoral Research Fellowship
Top contributors
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Medicine, University of Virginia
-
Lecturer in Psychology, Swansea University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Professor, Biology, York University, Canada
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW Sydney
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Bernard T. Ferrari Professor of Business, Johns Hopkins University
-
Dean and Professor of Public Health, The Ohio State University
-
Professor and Chair, Department of Journalism, Stellenbosch University
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Professor of Medicine, Epidemiologist, Physician, McMaster University
-
Postdoctoral fellow, McGill University
